Form 4: Amgen Director Michael V. Drake Reports Acquisition of Common Stock

Director Michael V. Drake reports acquiring Amgen common stock through vested Restricted Stock Units (RSUs) and dividend equivalents.

Summary

• On May 6, 2025, Michael V. Drake, a director of Amgen Inc., acquired common stock.
• The acquisition was through the vesting of Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Director Incentive Program.
• A total of 129.4187 shares were acquired at a price of $0.
• Following the transaction, Drake beneficially owns 3,737.5983 shares of Amgen common stock, including 196 Dividend Equivalents (DEs).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director, which generally indicates confidence but doesn't provide strong positive or negative signals.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates a director's acquisition of company stock, which is a common occurrence.

Stakeholder Impact

• The acquisition of shares by a director may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Amgen, Director, Michael V. Drake, Common Stock, RSU, Dividend Equivalents, Beneficial Ownership, Form 4